#18 - Richard Isaacson, M.D.: Alzheimer's prevention

Oct 1, 2018 Episode Page ↗
Overview

Dr. Richard Isaacson, Director of the Alzheimer's Prevention Clinic at Weill Cornell Medicine, discusses strategies for preventing Alzheimer's disease. He shares actionable insights on lifestyle, genetics, and biomarkers to reduce risk and delay onset, emphasizing a precision medicine approach.

At a Glance
30 Insights
2h 24m Duration
16 Topics
8 Concepts

Deep Dive Analysis

Richard Isaacson's Background and Unique Hobbies

Impetus for Focusing on Alzheimer's Prevention

Starting the Alzheimer's Prevention Clinic at Cornell

Diagnosing Alzheimer's Disease and Other Dementias

Understanding Cognitive Domains and Testing Challenges

Evolution of the Alzheimer's Prevention Field and Funding

The Role of the APOE Gene in Alzheimer's Risk

Why Alzheimer's Risk is Higher for Women

The MTHFR Gene and Metabolic Pathways to Alzheimer's

Multimodal Intervention: The 'ABCs' of Alzheimer's Prevention

Importance of Funding Alzheimer's Prevention Research

Specific Biomarkers and Their Significance

Statin Use and Individualized Alzheimer's Risk

Theracumin: A Specific Curcumin Formulation

Five Key Takeaways for Alzheimer's Prevention

Impact of Lifestyle and Mental Activity on Brain Health

Cognitive Aging

Non-pathological changes in cognition associated with age, where individuals may experience minor forgetfulness but can still function independently without alterations in activities of daily living.

Probable Alzheimer's Disease Dementia

A clinical diagnosis based on a history of progressive short-term memory loss and other cognitive changes, sometimes accompanied by sleep or behavioral issues, that cause a person to be unable to perform activities of daily living.

Preclinical Alzheimer's Disease

A stage where Alzheimer's pathology, such as amyloid deposition, is present in the brain, but the individual has not yet developed any cognitive symptoms.

Mild Cognitive Impairment (MCI) due to Alzheimer's Disease

A transitional phase between preclinical Alzheimer's and full dementia, where cognitive changes are noticeable but do not yet significantly impair a person's ability to function independently.

APOE Gene

A gene with three main variants (E2, E3, E4) that significantly influences an individual's genetic risk for Alzheimer's disease, with the E4 allele increasing risk and the E2 allele potentially decreasing it.

MTHFR Gene

The methyl tetrahydrofolate reductase gene, which, if it has multiple mutations, can lead to inefficiencies in metabolizing B vitamins, potentially causing elevated homocysteine levels and contributing to Alzheimer's risk through a metabolic pathway.

Alzheimer's as a Metabolic Disease

A perspective that views Alzheimer's disease, in the vast majority of cases, as stemming from mitochondrial dysfunction and bioenergetic problems in the brain, similar to type 2 diabetes.

Cognitive Reserve

The brain's ability to cope with damage or pathology by recruiting more efficient brain networks or alternative cognitive strategies, often built up through factors like educational attainment, musical experience, and mental engagement.

?
How is Alzheimer's disease diagnosed?

Traditionally, Alzheimer's is diagnosed clinically based on progressive short-term memory loss and other cognitive changes that impair daily living. However, modern approaches increasingly use biomarkers like amyloid PET scans or spinal fluid analysis to confirm the presence of Alzheimer's pathology.

?
How does Alzheimer's disease differ from other types of dementia?

Alzheimer's is the most common form of dementia, primarily characterized by progressive short-term memory loss. Other dementias, like frontotemporal dementia, present more with behavioral problems, while Lewy body dementia includes symptoms similar to Parkinson's disease along with dementia.

?
What is the prevalence of Alzheimer's disease in the United States?

Approximately 4 to 5 million Americans have dementia due to Alzheimer's. However, an estimated 47 million Americans have preclinical Alzheimer's disease, meaning they have the brain pathology but no symptoms yet.

?
How do people actually die from Alzheimer's disease?

Alzheimer's is an indirect cause of death. Patients often succumb to complications like infections (e.g., aspiration pneumonia, urosepsis) or failure to thrive, due to their inability to express symptoms or adequately care for themselves.

?
Can someone do everything right and still get Alzheimer's disease?

Yes, because Alzheimer's is a complex interplay of age, genetics, and environment. While lifestyle interventions can potentially prevent about one-third of cases, some individuals with strong genetic predispositions may still develop the disease despite optimal efforts.

?
Why is the risk of Alzheimer's higher for women?

Beyond women living longer, the perimenopause transition is believed to cause significant bioenergetic shifts in the brain, accelerating brain aging and increasing a woman's susceptibility to Alzheimer's disease due to hormonal changes.

?
What are the five most important things a person can do to reduce their risk for Alzheimer's disease?

The five key recommendations are: 1) Education about brain health, 2) Knowing one's personal health numbers, 3) Regular exercise (aerobic and strength training), 4) Vascular risk factor modification (blood pressure, cholesterol, diabetes control), and 5) Healthy nutrition (lower carbs, green leafy vegetables, blueberries).

?
Does mental activity help ward off Alzheimer's disease?

Yes, early life educational attainment and engaging in mentally stimulating activities, such as learning a musical instrument, can build up cognitive reserve, making individuals more resilient to the effects of Alzheimer's pathology and potentially delaying cognitive decline.

1. Adopt Precision Medicine Approach

Implement a personalized Alzheimer’s prevention plan by triangulating genetic, anthropometric, biomarker, and cognitive data to address individual risk factors. This comprehensive strategy ensures interventions are tailored to your unique biology.

2. Educate on Brain Health

Learn extensively about brain health through free online resources like ALZU.org, which offers interactive educational content. This foundational step empowers you to make informed incremental changes throughout your lifespan.

3. Engage in Regular Exercise

Make regular exercise your top priority, as it is the most impactful intervention shown to reduce or slow amyloid accumulation in the brain. Aim for at least 150-180 minutes of mixed aerobic and strength training weekly.

4. Manage Vascular Risk Factors

Aggressively control blood pressure, cholesterol, and diabetes, aiming for a systolic blood pressure of 120 mmHg, to significantly reduce the risk of mild cognitive impairment. This is a major, tangible step for brain health.

5. Prioritize Quality Sleep

Ensure you get adequate and quality sleep, as it is crucial for overall health, effective fat loss, and healthy aging. Poor sleep can accelerate brain aging and negatively impact cognitive function.

6. Optimize Brain-Healthy Nutrition

Adopt a nutrition plan that emphasizes lower ‘good’ carbohydrates, abundant green leafy vegetables, and includes blueberries for their antioxidant benefits. This dietary approach supports metabolic health and brain function.

7. Monitor Key Health Biomarkers

Know your numbers by regularly monitoring key health metrics such as blood pressure, pulse, body fat, weight, cholesterol (including advanced panels), and blood sugar. This data provides critical insights for personalized interventions.

8. Build Cognitive Reserve

Pursue lifelong learning, higher education, and musical experience to build cognitive reserve and resilience against Alzheimer’s disease. Staying mentally engaged helps strengthen brain pathways.

9. Reduce Sedentary Time

Minimize prolonged sitting, as it is considered detrimental to brain health, similar to the risks associated with smoking. Incorporate more movement throughout your day.

10. Implement Stress Reduction Techniques

Actively practice stress reduction techniques such as meditation or deep breathing to support overall well-being and brain health. Managing stress is a key component of a comprehensive prevention strategy.

11. Assess Body Composition

Go beyond just weight and BMI by assessing your body fat, lean mass, and visceral fat to understand your metabolic health. Managing visceral fat accumulation is crucial for protecting hippocampal volume and memory.

12. Target Optimal Fasting Glucose

Aim for a fasting blood sugar below 95 mg/dL for optimal brain health, as this cutoff is considered more appropriate for cognitive function than standard diabetes thresholds. This helps prevent metabolic issues that impact the brain.

13. Understand Family APOE Status

Learn your family’s APOE status, as this genetic information helps assess individual Alzheimer’s risk and guides personalized intervention strategies. Knowing your genetic predisposition allows for a more targeted approach.

14. Rule Out Reversible Causes

If experiencing cognitive decline, ensure you rule out reversible causes such as thyroid dysfunction or B12 deficiency. Addressing these underlying conditions can sometimes improve or resolve cognitive symptoms.

15. Treat Depression for Cognition

Seek treatment for depression, as it can significantly impact attention and memory, sometimes mimicking dementia. Addressing depression can lead to improved cognitive function.

16. Consider Hormone Replacement Therapy

For women in early perimenopause (first 2-7 years) with vascular risks, consider hormone replacement therapy (HRT) for potential brain health benefits. Consult with a specialized physician to balance risks and benefits.

17. Supplement B Vitamins for Homocysteine

If you have elevated homocysteine levels, supplement with B vitamins, using metabolically active forms like methylfolate and methyl B12 if traditional B vitamins are ineffective. This intervention is most effective when combined with optimized omega-3 fatty acids.

18. Supplement with DHA-Rich Omega-3s

Supplement with DHA-rich omega-3 fatty acids for brain health, especially if you are an ApoE4 carrier, as it can take years for effects to manifest. Tailor supplementation to individual needs based on biomarker levels.

19. Consider Theracumin for Amyloid

For individuals with amyloid in their brain, consider using Theracumin, a nanoparticle curcumin, which has been shown to reduce amyloid accumulation over 18 months. Personalize its use based on individual risk factors and biomarkers.

20. Get Diagnostic Brain Imaging

Undergo brain imaging, preferably an MRI, to rule out structural issues like tumors, assess vascular burden, and check for brain atrophy. This provides crucial information for diagnosis and personalized prevention.

21. Personalize Statin Use

If using statins, consider a personalized approach, being cautious with high-potency statins, especially for ApoE4 carriers, and exploring lower doses or alternative types. Different statins may have varied effects on individuals.

22. Consider Intermittent Fasting

Explore intermittent fasting, aiming for 16-hour fasting windows five times a week, for potential brain health benefits. This dietary pattern may support metabolic pathways relevant to cognitive function.

23. Moderate Alcohol Intake

Limit alcohol consumption to a maximum of 4 drinks per week for women and 7-10 drinks per week for men. The evidence on alcohol’s brain health benefits is murky, suggesting less is generally more.

24. Maintain Social Connections

Cultivate and maintain strong social connections and support systems, especially for caregivers, as social isolation and loss can accelerate cognitive decline. Collaborative relationships provide crucial cognitive and emotional support.

25. Utilize 23andMe Data

For deeper genetic insights, consider downloading your raw data from 23andMe and uploading it to services like Prometheus, in consultation with a doctor. This can help uncover additional genetic risk factors.

26. Consider Biomarker Testing

If exploring participation in Alzheimer’s clinical trials, consider biomarker testing (e.g., amyloid/tau scans or spinal fluid analysis) to confirm the presence of Alzheimer’s pathology. This is often a prerequisite for trial enrollment.

27. Seek Prevention Clinics

If available in your area, seek out specialized Alzheimer’s prevention clinics, such as those in the network mentioned, for comprehensive and personalized care. These clinics offer expertise in multimodal interventions.

28. Fund Prevention Research

Consider reallocating philanthropic funding towards Alzheimer’s prevention research, as this area is significantly underfunded compared to treatment research. Even modest contributions can have a remarkable impact.

29. Utilize Podcast Show Notes

Access the detailed show notes for this and every podcast episode on the website for more in-depth information, readings, and links related to the topics discussed. These notes are a valuable resource for further learning.

30. Leave a Podcast Review

If you enjoy the podcast, please consider leaving a positive review on platforms like Apple iTunes. This helps support the show and reach a wider audience.

Neurologic diagnosis should be made based on the history 80 to 90% of the time.

Richard Isaacson

Alzheimer's starts in the brain decades before the first symptom.

Richard Isaacson

Time is optionality.

Peter Attia

The success rate of pharmacology for Alzheimer's disease is 0.4%.

Peter Attia

Sitting is the new smoking.

Richard Isaacson

If you don't use it, you lose it.

Richard Isaacson

Alzheimer's Prevention Management: The 'ABCs' Approach

Richard Isaacson
  1. Assess Anthropometrics (A): Evaluate body fat, lean mass, and visceral fat distribution.
  2. Analyze Biomarkers (B): Conduct deep-dive blood tests including detailed cholesterol (e.g., LDL-P), inflammation (e.g., HSCRP), metabolism (e.g., HOMA-IR, fasting insulin/glucose), and nutritional biomarkers (serum levels).
  3. Evaluate Cognitive Function (C): Administer cognitive assessments looking at processing speed, attention, memory, and executive function.
  4. Triangulate Information: Combine insights from the anthropometric, biomarker, and cognitive data to make informed clinical decisions.
  5. Develop Personalized Plan: Create an evidence-based, safe, and individualized plan for the patient, including education, counseling, and specific lifestyle and supplement recommendations.
One out of every three
Approximate percentage of Alzheimer's cases that may be preventable Based on population attributable risk models, if a person does everything right.
0.4%
Success rate of pharmacology for Alzheimer's disease treatment 99.6% of drugs brought forth to treat Alzheimer's disease have been failures.
23
Richard Isaacson's age when he finished medical school He started college at 17 and completed a six-year medical program.
47 million
Estimated number of Americans with preclinical Alzheimer's disease These individuals have Alzheimer's pathology in their brain but no symptoms yet.
60-66%
Approximate percentage of US Alzheimer's patients with at least one APOE4 gene copy About one-quarter of the general population has an APOE4 gene.
120 mmHg
Target systolic blood pressure for cognitive benefit Identified by the SPRINT MIND study for reducing MCI risk.
19%
Reduction in mild cognitive impairment (MCI) development with tight blood pressure control Observed in the SPRINT MIND study after several years of treatment.
150 to 180 minutes
Recommended minimum aerobic exercise per week Often suggested as two-thirds cardio and one-third strength training, personalized to the individual.
Two and a half years
Time required for DHA to recycle in the brain Suggests long-term supplementation is needed for robust effects.
Four drinks per week
Richard Isaacson's recommended maximum alcohol intake for women Based on data related to body mass and muscle mass differences.
Seven to ten drinks per week
Richard Isaacson's recommended maximum alcohol intake for men Based on data related to body mass and muscle mass differences.
Less than 95 mg/dL
Richard Isaacson's cutoff for normal fasting blood sugar for brain health A stricter cutoff than general medical guidelines, based on specific brain health research.
Two pills a day (approx. 600mg)
Dose of Theracumin used in a study showing amyloid reduction Used in a study by Gary Small and colleagues over 18 months.